Summary

Asia Pacific Gene Expression Analysis Market is valued at approximately USD 880 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.93% over the forecast period 2024-2032. Gene expression analysis is the study of the activity of genes in a cell or tissue at a given moment. It involves measuring the levels of messenger RNA (mRNA) produced from each gene, as mRNA is the intermediate molecule between DNA and protein synthesis. This process provides insights into which genes are being actively transcribed and can give clues about the functional state of cells or tissues under different conditions. Moreover, the key trend of Gene Expression Analysis Market is growing investment in life science sectors for R&D. Countries such as China, India, Japan, and South Korea are investing heavily in research and development (R&D) in the life sciences sector. This includes genomics research, which fuels the demand for Gene Expression Analysis Market.

The Asia Pacific region is experiencing rapid growth in its biotechnology and pharmaceutical sectors. Companies in these industries are increasingly incorporating gene expression analysis into their drug discovery, development, and clinical trials processes. This growing industry demand is fueling the adoption of gene expression analysis technologies and services. Additionally, other factors support the market growth of Gene Expression Analysis Market in Asia Pacific are the increasing prevalence of chronic diseases, cohesive government initiatives and funding support, rising adoption of personalized medicine, increasing investments in life sciences research, and continuous advancements in gene expression analysis technologies, such as next-generation sequencing (NGS), microarray analysis, quantitative PCR (qPCR), and single-cell analysis techniques are driving market growth. However, a scarcity of experienced labour and the high cost of the instruments are expected to hinder market expansion over the projection period 2024-2032.

The key Countries considered for the Asia Pacific Gene Expression Analysis market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China was the largest regional market. The Gene Expression Analysis market in China is driven by the growing research and development activities, rising demand for personalized medicine, and rapid expansion of biotechnology and pharmaceutical industries that are anticipated to support the market growth. Also, increased investment in biotechnology R&D in China fosters the development of advanced research facilities, equipped for genomics research and gene expression analysis. This enhances the capability of Chinese institutions and companies to conduct comprehensive studies on gene expression patterns in diverse biological systems and diseases. For instance, in Aug. 2023, Novo Holdings invested USD 290 million in Chinese life sciences company Sangon Biotech, specializing in DNA synthesis, genetic sequencing, and protein- and antibody-related drug research. This funding underscores Sangon's significance as a leading enabler of life sciences research in China, enhancing its capabilities and market presence.

Major market player included in this report are:
Takara Bio Inc
BGI Group
Royo Biotechnology Co., Ltd.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Technology
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Microarrays
Others

By Product Type
Instruments
Reagents and Consumables
Services

By End-user
Drug Discovery & Development
Diagnostic Laboratories
Academic Research Centers
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Asia Pacific Gene Expression Analysis Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Asia Pacific Gene Expression Analysis Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Technology
2.3.2. By Product Type
2.3.3. By End-user
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Gene Expression Analysis Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Gene Expression Analysis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Gene Expression Analysis Market Size & Forecasts by Technology 2022-2032
5.1. Polymerase Chain Reaction (PCR)
5.2. Next Generation Sequencing (NGS)
5.3. Microarrays
5.4. Others
Chapter 6. Asia Pacific Gene Expression Analysis Market Size & Forecasts by Product Type 2022-2032
6.1. Instruments
6.2. Reagents and Consumables
6.3. Services
Chapter 7. Asia Pacific Gene Expression Analysis Market Size & Forecasts by End-User 2022-2032
7.1. Drug Discovery & Development
7.2. Diagnostic Laboratories
7.3. Academic Research Centers
Chapter 8. Asia Pacific Gene Expression Analysis Market Size & Forecasts by Country 2022-2032
8.1. China Gene Expression Analysis Market
8.1.1. Technology breakdown size & forecasts, 2022-2032
8.1.2. Product Type breakdown size & forecasts, 2022-2032
8.1.3. End-user breakdown size & forecasts, 2022-2032
8.2. India Gene Expression Analysis Market
8.3. Japan Gene Expression Analysis Market
8.4. Australia Gene Expression Analysis Market
8.5. South Korea Gene Expression Analysis Market
8.6. Rest of Asia Pacific Gene Expression Analysis Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Takara Bio Inc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. BGI Group
9.3.3. Royo Biotechnology Co., Ltd.
9.3.4. Company 4
9.3.5. Company 5
9.3.6. Company 6
9.3.7. Company 7
9.3.8. Company 8
9.3.9. Company 9
9.3.10. Company 10
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes